Total U.S. drug spending was $535.3 billion in 2020. The drug spending categories that experienced the biggest increases were home healthcare (13 percent), mail-order prescriptions (9 percent) and clinics (8 percent).
Drug spending at hospitals decreased by 5 percent, as patients delaying care amid the pandemic correlated with decreased drug utilization in hospitals.
Several new drugs that could affect the country’s drug spending levels are expected to be approved in 2021, according to the report. The authors predicted total drug spending will rise by 4 to 6 percent in 2021. For clinics and hospitals, they predicted drug spending would rise by 7 to 9 percent and 3 to 5 percent, respectively.
More articles on pharmacy:
US will run out of enthusiastic vaccine recipients soon, KFF predicts
US hits 200M COVID-19 vaccinations within Biden’s first 100 days
FDA cites 9 violations after probe of Baltimore plant making J&J vaccine
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
